Cargando…
In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis
BACKGROUND: The increasing incidence of drug-resistant Mycobacterium tuberculosis necessitates therapeutic alternatives. The fluoroquinolones fulfill most of the criteria for an ideal class of antimycobacterial drugs. The aim of the present study was to determine to in vitro activities of ciprofloxa...
Autores principales: | Akcali, Sinem, Surucuoglu, Suheyla, Cicek, Candan, Ozbakkaloglu, Beril |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089726/ https://www.ncbi.nlm.nih.gov/pubmed/16270765 http://dx.doi.org/10.5144/0256-4947.2005.409 |
Ejemplares similares
-
Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China
por: Kong, Yaoyao, et al.
Publicado: (2023) -
Prevalence of GBV-C/hepatitis G virus viremia among chronic hepatitis B, chronic hepatitis C and hemodialysis patients in Turkey
por: Akcali, Sinem, et al.
Publicado: (2006) -
Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis
por: Sihotang, Tiar Sondang Uli, et al.
Publicado: (2022) -
Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea
por: Cho, Yongil, et al.
Publicado: (2018) -
Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin
por: Yu, Xia, et al.
Publicado: (2016)